Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Merck
Moodys
Baxter
AstraZeneca

Last Updated: August 19, 2022

Investigational Drug Information for Basmisanil


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for Basmisanil?

Basmisanil is an investigational drug.

There have been 4 clinical trials for Basmisanil. The most recent clinical trial was a Phase 2 trial, which was initiated on March 30th 2022.

The most common disease conditions in clinical trials are Stroke, Ischemic Stroke, and Down Syndrome. The leading clinical trial sponsors are Hoffmann-La Roche and [disabled in preview].

There are thirteen US patents protecting this investigational drug and one hundred and sixty-two international patents.

Recent Clinical Trials for Basmisanil
TitleSponsorPhase
A Study to Evaluate the Safety and Efficacy of Basmisanil Treatment in Children With Dup15q SyndromeHoffmann-La RochePhase 2
A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic StrokeHoffmann-La RochePhase 2
A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With AntipsychoticsHoffmann-La RochePhase 2

See all Basmisanil clinical trials

Clinical Trial Summary for Basmisanil

Top disease conditions for Basmisanil
Top clinical trial sponsors for Basmisanil

See all Basmisanil clinical trials

US Patents for Basmisanil

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Basmisanil See Plans and Pricing Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) See Plans and Pricing
Basmisanil See Plans and Pricing Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN) See Plans and Pricing
Basmisanil See Plans and Pricing Compartmented pharmaceutical dosage forms Triastek, Inc. (Nanjing, CN) See Plans and Pricing
Basmisanil See Plans and Pricing Compositions and methods for neurological diseases Coda Biotherapeutics, Inc. (South San Francisco, CA) See Plans and Pricing
Basmisanil See Plans and Pricing Isoxazolo-pyridine derivatives Hoffmann-La Roche Inc (Nutley, NJ) See Plans and Pricing
Basmisanil See Plans and Pricing Process for the preparation of isoxazolyl-methoxy nicotinic acids Hoffman-La Roche Inc. (Nutley, NJ) See Plans and Pricing
Basmisanil See Plans and Pricing Solid forms Hoffmann-La Roche Inc. (Nutley, NJ) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Basmisanil

Drugname Country Document Number Estimated Expiration Related US Patent
Basmisanil Australia AU2017261372 2036-05-05 See Plans and Pricing
Basmisanil Canada CA3023278 2036-05-05 See Plans and Pricing
Basmisanil China CN107847398 2036-05-05 See Plans and Pricing
Basmisanil European Patent Office EP3452003 2036-05-05 See Plans and Pricing
Basmisanil European Patent Office EP3981392 2036-05-05 See Plans and Pricing
Basmisanil Hong Kong HK1249728 2036-05-05 See Plans and Pricing
Basmisanil Japan JP2019520866 2036-05-05 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Merck
Moodys
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.